01875

3.3751.50%
CH

Chaohong Hu

Independent Non-executive Director

Dr. Chaohong Hu, also known as Mary, is Independent Non-executive Director of BioDlink International Company Limited from April 29, 2026. She is Independent Non-Executive Director since November 21, 2024 at HUTCHMED (China) Limited. She has been Co-Chief Executive Officer at Lepu Biopharma Co., Ltd and has been its Executive Director since May 16, 2020. She joined Lepu Biopharma Co., Ltd. in July 2018. She is the Chairman of the board and general manager of Miracogen Shanghai, a company founded by Dr. Hu in 2014 and director of Innocube Limited. Dr. Hu has experience in development of therapeutic antibodies, antibody drug conjugates and vaccines. Prior to founding Miracogen Shanghai, Dr. Hu served as a director of the Bioassay Development and Process Analytics department at Seagen Inc. from June 2007 to October 2013, the head of Molecular Biology and Clinical Immunology department of GlaxoSmithKline plc from January 2006 to May 2007, the research scientist and director of Molecular Biology and Clinical Immunology department of ID Biomedical Corporation, previously known as ID Vaccine Corporation, from October 1997 to December 2005, a postdoctoral fellow of the University of Washington from September 1992 to October 1997. Dr. Hu obtained a bachelor's degree in biochemistry from Wuhan University in the PRC in July 1986 and a doctoral degree in science from Institute of Biophysics, Chinese Academy of Sciences in July 1991. Dr. Hu was awarded the second prize of National Natural Science Award by the State Council of the PRC in 1995.

Positions